<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01211600</url>
  </required_header>
  <id_info>
    <org_study_id>10D.199</org_study_id>
    <nct_id>NCT01211600</nct_id>
  </id_info>
  <brief_title>Cesarean Trial of Staples vs. Sutures</brief_title>
  <acronym>CROSS</acronym>
  <official_title>Cesarean Randomized Control Trial Of Sutures vs. Staples (CROSS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Thomas Jefferson University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Main Line Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Thomas Jefferson University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine whether the rate of wound complications differs based on method of closure of
      skin incision (staples vs. suture) after cesarean delivery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Despite this large number of cesareans performed annually, there is a paucity of data to
      suggest which technique is superior for closure of the skin incision with regards to wound
      complications, including wound separation and infection. As the morbidity associated with a
      cesarean delivery is usually related to wound complications, especially infection, we feel
      that it is important to examine this outcome by comparing the current skin closure
      techniques: staples versus suture.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2010</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Wound Complications</measure>
    <time_frame>Within 6 weeks of postpartum</time_frame>
    <description>The primary outcome is to evaluate the rate of wound complications for patients undergoing cesarean whose skin incision is closed with staples versus with suture.
Wound complications included infection, hematoma, seroma, and separation and readmission for wound complication.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient Scar Assessment Scale Scores for Evaluation of Cosmesis</measure>
    <time_frame>Immediately postpartum and 4 - 8 weeks after intervention, up to 12 weeks.</time_frame>
    <description>Patient evaluation of cosmesis of the cesarean incision based on closure method: staples vs sutures.
Surgical scars were evaluated using Patient Scar Assessment Scale (PSAS). The PSAS evaluates six items: pain, itchiness, color, stiffness, thickness, and irregularity. Each item is scored on a 10-point scale comparing the patient's skin to normal skin, in which one represents normal skin. The score is summed, range 6-60. Lower scores indicate closer resemblance to normal skin and are superior.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction With Closure Method and Scar Appearance</measure>
    <time_frame>Immediately postpartum and 4 - 8 weeks after intervention, up to 12 weeks.</time_frame>
    <description>Whether the patient's satisfaction with the incision differed based on closure method (staples vs sutures) using 10-point Likert scale on which 1 is completely dissatisfied and 10 is completely satisfied.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Perception</measure>
    <time_frame>Immediately postpartum to time of discharge, which is typically 3-4 days post-cesarean</time_frame>
    <description>Whether the patient's perception of pain associated with the incision differed based on closure method (staples vs sutures). Patients were asked to rate pain on a scale from 0 (no pain) to 10 (extreme pain) using a visual graph of facial expressions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Additional Provider Visits</measure>
    <time_frame>Within 6 weeks postpartum</time_frame>
    <description>Mean number of visits per participant (All wound visits, number of visits for women who were diagnosed with wound complications, number of visits for women who were not diagnosed with a wound complication).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Primary Versus Repeat Cesarean</measure>
    <time_frame>At randomization.</time_frame>
    <description>Randomization stratum - BMI (over/under 30) and Cesarean (primary or repeat)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative Trial Details - Duration of Operation and Skin Closure</measure>
    <time_frame>Time of Cesarean</time_frame>
    <description>Duration of operation: skin incision to skin closure Duration of skin closure: fascial closure to skin closure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative Trial Details - Closure of Subcutaneous Tissue</measure>
    <time_frame>Time of Cesarean</time_frame>
    <description>Number of participants requiring subcutaneous tissue closure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Hospital Stay</measure>
    <time_frame>Immediate postpartum.</time_frame>
    <description>Length of hospital stay (days)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants That Received Anticoagulation Within 24 Hours</measure>
    <time_frame>Within 24 hours postpartum.</time_frame>
    <description>Number of participants that received anticoagulation within 24 hours of procedure (preoperatively or postoperatively)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Diagnosed With Endomyometritis</measure>
    <time_frame>Immediate postpartum.</time_frame>
    <description>Number of participants diagnosed with endomyometritis requiring antibiotics</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Hemoglobin Pre-operatively to Post-operatively</measure>
    <time_frame>Up to 72 hours before and 24 hours after cesarean.</time_frame>
    <description>Median change in hemoglobin from preoperative value (g/dL) to post-operatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Observer Evaluation of Cosmesis of the Cesarean Incision Based on Closure Method: Staples vs Sutures.</measure>
    <time_frame>Immediately postpartum and 4 - 8 weeks after intervention, up to 12 weeks.</time_frame>
    <description>Surgical scars were evaluated using Observer Scar Assessment Scale (OSAS). The OSAS evaluates five items: vascularity, pigmentation, thickness, relief, and pliability. Each item is scored on a 10-point scale comparing the patient's skin to normal skin, in which one represents normal skin. The score is summed, range 5-50. Lower scores indicate closer resemblance to normal skin and are superior.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">746</enrollment>
  <condition>Cesarean Section</condition>
  <condition>Wound Complications</condition>
  <condition>Patient Satisfaction</condition>
  <condition>Pain Measurement</condition>
  <arm_group>
    <arm_group_label>Staples</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Interrupted Ethicon Staples</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Suture</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subcuticular continuous suture (4-0 Monocryl Plus on PS2 needle or 4-0 Vicryl Plus on FS2 or PS2 needle)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Staples</intervention_name>
    <description>Interrupted Ethicon Staples</description>
    <arm_group_label>Staples</arm_group_label>
    <other_name>Closure Technique</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Suture</intervention_name>
    <description>Subcuticular continuous suture (4-0 Monocryl Plus on PS2 needle or 4-0 Vicryl Plus on FS2 or PS2 needle)</description>
    <arm_group_label>Suture</arm_group_label>
    <other_name>Closure Technique</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women undergoing cesarean delivery for pregnancy greater than 23 weeks gestation.

        Exclusion Criteria:

          -  Poorly controlled diabetes (defined as â‰¥ 50% of fasting or 2 hour postprandial glucose
             levels &gt; 95 and 120 respectively within the week prior to delivery),

          -  Vertical skin incisions

          -  Chronic steroid use

          -  Active lupus flare

          -  HIV/AIDS

          -  Current treatment for cancer or a history of radiation to the abdomen/pelvis

          -  Current treatment with immunosuppressant medications secondary to history of
             transplantation

          -  Emergency cesarean(precluding informed consent prior to surgery)

          -  Lack of access to a phone

          -  Allergy to suture or staple material
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>A. Dhanya Mackeen, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Thomas Jefferson University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Yale University</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Rousseau JA, Girard K, Turcot-Lemay L, Thomas N. A randomized study comparing skin closure in cesarean sections: staples vs subcuticular sutures. Am J Obstet Gynecol. 2009 Mar;200(3):265.e1-4. doi: 10.1016/j.ajog.2009.01.019.</citation>
    <PMID>19254586</PMID>
  </reference>
  <reference>
    <citation>Frishman GN, Schwartz T, Hogan JW. Closure of Pfannenstiel skin incisions. Staples vs. subcuticular suture. J Reprod Med. 1997 Oct;42(10):627-30.</citation>
    <PMID>9350017</PMID>
  </reference>
  <reference>
    <citation>Alderdice F, McKenna D, Dornan J. Techniques and materials for skin closure in caesarean section. Cochrane Database Syst Rev. 2003;(2):CD003577. Review. Update in: Cochrane Database Syst Rev. 2012;9:CD003577.</citation>
    <PMID>12804476</PMID>
  </reference>
  <reference>
    <citation>Basha SL, Rochon ML, QuiÃ±ones JN, Coassolo KM, Rust OA, Smulian JC. Randomized controlled trial of wound complication rates of subcuticular suture vs staples for skin closure at cesarean delivery. Am J Obstet Gynecol. 2010 Sep;203(3):285.e1-8. doi: 10.1016/j.ajog.2010.07.011.</citation>
    <PMID>20816153</PMID>
  </reference>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>September 28, 2010</study_first_submitted>
  <study_first_submitted_qc>September 28, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 29, 2010</study_first_posted>
  <results_first_submitted>May 28, 2019</results_first_submitted>
  <results_first_submitted_qc>November 7, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">November 26, 2019</results_first_posted>
  <last_update_submitted>November 7, 2019</last_update_submitted>
  <last_update_submitted_qc>November 7, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Staples</keyword>
  <keyword>Sutures</keyword>
  <keyword>Wound infections</keyword>
  <keyword>Cosmesis</keyword>
  <keyword>Aesthetic appearance of skin incision</keyword>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Suture</title>
          <description>Subcuticular continuous suture (4-0 Monocryl Plus on PS2 needle or 4-0 Vicryl Plus on FS2 or PS2 needle)</description>
        </group>
        <group group_id="P2">
          <title>Staples</title>
          <description>Interrupted Ethicon Staples</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="370"/>
                <participants group_id="P2" count="376"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="370"/>
                <participants group_id="P2" count="376"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Suture</title>
          <description>Subcuticular continuous suture (4-0 Monocryl Plus on PS2 needle or 4-0 Vicryl Plus on FS2 or PS2 needle)</description>
        </group>
        <group group_id="B2">
          <title>Staples</title>
          <description>Interrupted Ethicon Staples</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="370"/>
            <count group_id="B2" value="376"/>
            <count group_id="B3" value="746"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31.0" lower_limit="26.9" upper_limit="35.4"/>
                    <measurement group_id="B2" value="31.0" lower_limit="26.4" upper_limit="35.6"/>
                    <measurement group_id="B3" value="31.0" lower_limit="26.6" upper_limit="35.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="370"/>
                    <measurement group_id="B2" value="376"/>
                    <measurement group_id="B3" value="746"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="158"/>
                    <measurement group_id="B2" value="167"/>
                    <measurement group_id="B3" value="325"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Caucasian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="162"/>
                    <measurement group_id="B2" value="154"/>
                    <measurement group_id="B3" value="316"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Hispanic</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="43"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Other</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Pregnancy History - Singleton Gestation</title>
          <description>Number of participants with singleton pregnancy</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="353"/>
                    <measurement group_id="B2" value="351"/>
                    <measurement group_id="B3" value="704"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of Previous Cesareans</title>
          <description>Participants who had 0, 1, or more than one cesarean prior to study participation</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>0 Previous Cesareans</title>
                  <measurement_list>
                    <measurement group_id="B1" value="180"/>
                    <measurement group_id="B2" value="177"/>
                    <measurement group_id="B3" value="357"/>
                  </measurement_list>
                </category>
                <category>
                  <title>1 Previous Cesarean</title>
                  <measurement_list>
                    <measurement group_id="B1" value="120"/>
                    <measurement group_id="B2" value="132"/>
                    <measurement group_id="B3" value="252"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than 1 Previous Cesarean</title>
                  <measurement_list>
                    <measurement group_id="B1" value="70"/>
                    <measurement group_id="B2" value="67"/>
                    <measurement group_id="B3" value="137"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Term Gestation</title>
          <description>Number of participants at 37 weeks or greater gestation at time of participation.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="317"/>
                    <measurement group_id="B2" value="329"/>
                    <measurement group_id="B3" value="646"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Wound Complications</title>
        <description>The primary outcome is to evaluate the rate of wound complications for patients undergoing cesarean whose skin incision is closed with staples versus with suture.
Wound complications included infection, hematoma, seroma, and separation and readmission for wound complication.</description>
        <time_frame>Within 6 weeks of postpartum</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Suture</title>
            <description>Subcuticular continuous suture (4-0 Monocryl Plus on PS2 needle or 4-0 Vicryl Plus on FS2 or PS2 needle)</description>
          </group>
          <group group_id="O2">
            <title>Staples</title>
            <description>Interrupted Ethicon Staples</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Wound Complications</title>
          <description>The primary outcome is to evaluate the rate of wound complications for patients undergoing cesarean whose skin incision is closed with staples versus with suture.
Wound complications included infection, hematoma, seroma, and separation and readmission for wound complication.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="370"/>
                <count group_id="O2" value="376"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Total patients with at least 1 wound complicatin</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Infection</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hematoma</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seroma</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Separation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Readmission for wound complication</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Scar Assessment Scale Scores for Evaluation of Cosmesis</title>
        <description>Patient evaluation of cosmesis of the cesarean incision based on closure method: staples vs sutures.
Surgical scars were evaluated using Patient Scar Assessment Scale (PSAS). The PSAS evaluates six items: pain, itchiness, color, stiffness, thickness, and irregularity. Each item is scored on a 10-point scale comparing the patient's skin to normal skin, in which one represents normal skin. The score is summed, range 6-60. Lower scores indicate closer resemblance to normal skin and are superior.</description>
        <time_frame>Immediately postpartum and 4 - 8 weeks after intervention, up to 12 weeks.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Suture</title>
            <description>Subcuticular continuous suture (4-0 Monocryl Plus on PS2 needle or 4-0 Vicryl Plus on FS2 or PS2 needle)</description>
          </group>
          <group group_id="O2">
            <title>Staples</title>
            <description>Interrupted Ethicon Staples</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Scar Assessment Scale Scores for Evaluation of Cosmesis</title>
          <description>Patient evaluation of cosmesis of the cesarean incision based on closure method: staples vs sutures.
Surgical scars were evaluated using Patient Scar Assessment Scale (PSAS). The PSAS evaluates six items: pain, itchiness, color, stiffness, thickness, and irregularity. Each item is scored on a 10-point scale comparing the patient's skin to normal skin, in which one represents normal skin. The score is summed, range 6-60. Lower scores indicate closer resemblance to normal skin and are superior.</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="286"/>
                <count group_id="O2" value="291"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15" lower_limit="10" upper_limit="25"/>
                    <measurement group_id="O2" value="20" lower_limit="11" upper_limit="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Satisfaction With Closure Method and Scar Appearance</title>
        <description>Whether the patient's satisfaction with the incision differed based on closure method (staples vs sutures) using 10-point Likert scale on which 1 is completely dissatisfied and 10 is completely satisfied.</description>
        <time_frame>Immediately postpartum and 4 - 8 weeks after intervention, up to 12 weeks.</time_frame>
        <population>Patient satisfaction data were available for 606 participants. Two participants in the Staples arm did not provide scores for scar appearance satisfaction. This is why we are representing 305 of the 307 subjects' responses to satisfaction of scar appearance.</population>
        <group_list>
          <group group_id="O1">
            <title>Staples</title>
            <description>Interrupted Ethicon Staples
Staples: Interrupted Ethicon Staples</description>
          </group>
          <group group_id="O2">
            <title>Suture</title>
            <description>Subcuticular continuous suture (4-0 Monocryl Plus on PS2 needle or 4-0 Vicryl Plus on FS2 or PS2 needle)
Suture: Subcuticular continuous suture (4-0 Monocryl Plus on PS2 needle or 4-0 Vicryl Plus on FS2 or PS2 needle)</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Satisfaction With Closure Method and Scar Appearance</title>
          <description>Whether the patient's satisfaction with the incision differed based on closure method (staples vs sutures) using 10-point Likert scale on which 1 is completely dissatisfied and 10 is completely satisfied.</description>
          <population>Patient satisfaction data were available for 606 participants. Two participants in the Staples arm did not provide scores for scar appearance satisfaction. This is why we are representing 305 of the 307 subjects' responses to satisfaction of scar appearance.</population>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="307"/>
                <count group_id="O2" value="299"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Satisfaction with Closure Method</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="307"/>
                    <count group_id="O2" value="299"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9" lower_limit="6" upper_limit="10"/>
                    <measurement group_id="O2" value="10" lower_limit="9" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with Scar Appearance</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="305"/>
                    <count group_id="O2" value="299"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9" lower_limit="7" upper_limit="10"/>
                    <measurement group_id="O2" value="9" lower_limit="8" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Perception</title>
        <description>Whether the patient's perception of pain associated with the incision differed based on closure method (staples vs sutures). Patients were asked to rate pain on a scale from 0 (no pain) to 10 (extreme pain) using a visual graph of facial expressions.</description>
        <time_frame>Immediately postpartum to time of discharge, which is typically 3-4 days post-cesarean</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Suture</title>
            <description>Subcuticular continuous suture (4-0 Monocryl Plus on PS2 needle or 4-0 Vicryl Plus on FS2 or PS2 needle)</description>
          </group>
          <group group_id="O2">
            <title>Staples</title>
            <description>Interrupted Ethicon Staples</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Perception</title>
          <description>Whether the patient's perception of pain associated with the incision differed based on closure method (staples vs sutures). Patients were asked to rate pain on a scale from 0 (no pain) to 10 (extreme pain) using a visual graph of facial expressions.</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="370"/>
                <count group_id="O2" value="376"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Less than 24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5" lower_limit="2.0" upper_limit="5.0"/>
                    <measurement group_id="O2" value="3.6" lower_limit="2.2" upper_limit="5.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 - 47 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.3" lower_limit="3.5" upper_limit="5.2"/>
                    <measurement group_id="O2" value="4.3" lower_limit="3.4" upper_limit="5.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 - 72 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.3" lower_limit="3.5" upper_limit="5.3"/>
                    <measurement group_id="O2" value="4.2" lower_limit="3.3" upper_limit="5.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain at time of Discharge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5" lower_limit="2.0" upper_limit="5.0"/>
                    <measurement group_id="O2" value="3.6" lower_limit="2.2" upper_limit="5.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Additional Provider Visits</title>
        <description>Mean number of visits per participant (All wound visits, number of visits for women who were diagnosed with wound complications, number of visits for women who were not diagnosed with a wound complication).</description>
        <time_frame>Within 6 weeks postpartum</time_frame>
        <population>The number analyzed in the &quot;Number of visits - diagnosed wound complication&quot; and &quot;Number of visits - no diagnosed wound complication&quot; rows indicates the breakdown of subjects within each arm that did and did not have a diagnosed wound complication.</population>
        <group_list>
          <group group_id="O1">
            <title>Suture</title>
            <description>Subcuticular continuous suture (4-0 Monocryl Plus on PS2 needle or 4-0 Vicryl Plus on FS2 or PS2 needle)</description>
          </group>
          <group group_id="O2">
            <title>Staples</title>
            <description>Interrupted Ethicon Staples</description>
          </group>
        </group_list>
        <measure>
          <title>Additional Provider Visits</title>
          <description>Mean number of visits per participant (All wound visits, number of visits for women who were diagnosed with wound complications, number of visits for women who were not diagnosed with a wound complication).</description>
          <population>The number analyzed in the &quot;Number of visits - diagnosed wound complication&quot; and &quot;Number of visits - no diagnosed wound complication&quot; rows indicates the breakdown of subjects within each arm that did and did not have a diagnosed wound complication.</population>
          <units>Number of Visits per participant</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="370"/>
                <count group_id="O2" value="376"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>All wound visits</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="370"/>
                    <count group_id="O2" value="376"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".9" lower_limit="0" upper_limit="7"/>
                    <measurement group_id="O2" value="1.5" lower_limit="0" upper_limit="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Number of visits - diagnosed wound complication</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.7" lower_limit="1" upper_limit="7"/>
                    <measurement group_id="O2" value="2.9" lower_limit="1" upper_limit="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Number of visits - no diagnosed wound complication</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="352"/>
                    <count group_id="O2" value="336"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".8" lower_limit="0" upper_limit="3"/>
                    <measurement group_id="O2" value="1.4" lower_limit="0" upper_limit="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Primary Versus Repeat Cesarean</title>
        <description>Randomization stratum - BMI (over/under 30) and Cesarean (primary or repeat)</description>
        <time_frame>At randomization.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Suture</title>
            <description>Subcuticular continuous suture (4-0 Monocryl Plus on PS2 needle or 4-0 Vicryl Plus on FS2 or PS2 needle)</description>
          </group>
          <group group_id="O2">
            <title>Staples</title>
            <description>Interrupted Ethicon Staples</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Primary Versus Repeat Cesarean</title>
          <description>Randomization stratum - BMI (over/under 30) and Cesarean (primary or repeat)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="370"/>
                <count group_id="O2" value="376"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>BMI 30 or greater - primary cesarean delivery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="109"/>
                    <measurement group_id="O2" value="106"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BMI 30 or greater - repeat cesarean delivery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="126"/>
                    <measurement group_id="O2" value="132"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BMI less than 30 - primary cesarean delivery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71"/>
                    <measurement group_id="O2" value="71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BMI less than 30 - repeat cesarean delivery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64"/>
                    <measurement group_id="O2" value="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intraoperative Trial Details - Duration of Operation and Skin Closure</title>
        <description>Duration of operation: skin incision to skin closure Duration of skin closure: fascial closure to skin closure</description>
        <time_frame>Time of Cesarean</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Suture</title>
            <description>Subcuticular continuous suture (4-0 Monocryl Plus on PS2 needle or 4-0 Vicryl Plus on FS2 or PS2 needle)</description>
          </group>
          <group group_id="O2">
            <title>Staples</title>
            <description>Interrupted Ethicon Staples</description>
          </group>
        </group_list>
        <measure>
          <title>Intraoperative Trial Details - Duration of Operation and Skin Closure</title>
          <description>Duration of operation: skin incision to skin closure Duration of skin closure: fascial closure to skin closure</description>
          <units>Minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="370"/>
                <count group_id="O2" value="376"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Duration of Operation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58.5" lower_limit="46.5" upper_limit="75"/>
                    <measurement group_id="O2" value="51" lower_limit="40" upper_limit="65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Duration of Skin Closure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15" lower_limit="12" upper_limit="19"/>
                    <measurement group_id="O2" value="6" lower_limit="4" upper_limit="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intraoperative Trial Details - Closure of Subcutaneous Tissue</title>
        <description>Number of participants requiring subcutaneous tissue closure</description>
        <time_frame>Time of Cesarean</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Suture</title>
            <description>Subcuticular continuous suture (4-0 Monocryl Plus on PS2 needle or 4-0 Vicryl Plus on FS2 or PS2 needle)</description>
          </group>
          <group group_id="O2">
            <title>Staples</title>
            <description>Interrupted Ethicon Staples</description>
          </group>
        </group_list>
        <measure>
          <title>Intraoperative Trial Details - Closure of Subcutaneous Tissue</title>
          <description>Number of participants requiring subcutaneous tissue closure</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="370"/>
                <count group_id="O2" value="376"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="201"/>
                    <measurement group_id="O2" value="202"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Hospital Stay</title>
        <description>Length of hospital stay (days)</description>
        <time_frame>Immediate postpartum.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Suture</title>
            <description>Subcuticular continuous suture (4-0 Monocryl Plus on PS2 needle or 4-0 Vicryl Plus on FS2 or PS2 needle)</description>
          </group>
          <group group_id="O2">
            <title>Staples</title>
            <description>Interrupted Ethicon Staples</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Hospital Stay</title>
          <description>Length of hospital stay (days)</description>
          <units>Days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="370"/>
                <count group_id="O2" value="376"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.4" lower_limit="1" upper_limit="8"/>
                    <measurement group_id="O2" value="4.5" lower_limit="3" upper_limit="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants That Received Anticoagulation Within 24 Hours</title>
        <description>Number of participants that received anticoagulation within 24 hours of procedure (preoperatively or postoperatively)</description>
        <time_frame>Within 24 hours postpartum.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Suture</title>
            <description>Subcuticular continuous suture (4-0 Monocryl Plus on PS2 needle or 4-0 Vicryl Plus on FS2 or PS2 needle)</description>
          </group>
          <group group_id="O2">
            <title>Staples</title>
            <description>Interrupted Ethicon Staples</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants That Received Anticoagulation Within 24 Hours</title>
          <description>Number of participants that received anticoagulation within 24 hours of procedure (preoperatively or postoperatively)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="370"/>
                <count group_id="O2" value="376"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Diagnosed With Endomyometritis</title>
        <description>Number of participants diagnosed with endomyometritis requiring antibiotics</description>
        <time_frame>Immediate postpartum.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Suture</title>
            <description>Subcuticular continuous suture (4-0 Monocryl Plus on PS2 needle or 4-0 Vicryl Plus on FS2 or PS2 needle)</description>
          </group>
          <group group_id="O2">
            <title>Staples</title>
            <description>Interrupted Ethicon Staples</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Diagnosed With Endomyometritis</title>
          <description>Number of participants diagnosed with endomyometritis requiring antibiotics</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="370"/>
                <count group_id="O2" value="376"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Hemoglobin Pre-operatively to Post-operatively</title>
        <description>Median change in hemoglobin from preoperative value (g/dL) to post-operatively.</description>
        <time_frame>Up to 72 hours before and 24 hours after cesarean.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Suture</title>
            <description>Subcuticular continuous suture (4-0 Monocryl Plus on PS2 needle or 4-0 Vicryl Plus on FS2 or PS2 needle)</description>
          </group>
          <group group_id="O2">
            <title>Staples</title>
            <description>Interrupted Ethicon Staples</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Hemoglobin Pre-operatively to Post-operatively</title>
          <description>Median change in hemoglobin from preoperative value (g/dL) to post-operatively.</description>
          <units>g/dL</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="370"/>
                <count group_id="O2" value="376"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.8" lower_limit="-2.5" upper_limit="-1.2"/>
                    <measurement group_id="O2" value="-1.8" lower_limit="-2.5" upper_limit="-1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Observer Evaluation of Cosmesis of the Cesarean Incision Based on Closure Method: Staples vs Sutures.</title>
        <description>Surgical scars were evaluated using Observer Scar Assessment Scale (OSAS). The OSAS evaluates five items: vascularity, pigmentation, thickness, relief, and pliability. Each item is scored on a 10-point scale comparing the patient's skin to normal skin, in which one represents normal skin. The score is summed, range 5-50. Lower scores indicate closer resemblance to normal skin and are superior.</description>
        <time_frame>Immediately postpartum and 4 - 8 weeks after intervention, up to 12 weeks.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Suture</title>
            <description>Subcuticular continuous suture (4-0 Monocryl Plus on PS2 needle or 4-0 Vicryl Plus on FS2 or PS2 needle)</description>
          </group>
          <group group_id="O2">
            <title>Staples</title>
            <description>Interrupted Ethicon Staples</description>
          </group>
        </group_list>
        <measure>
          <title>Observer Evaluation of Cosmesis of the Cesarean Incision Based on Closure Method: Staples vs Sutures.</title>
          <description>Surgical scars were evaluated using Observer Scar Assessment Scale (OSAS). The OSAS evaluates five items: vascularity, pigmentation, thickness, relief, and pliability. Each item is scored on a 10-point scale comparing the patient's skin to normal skin, in which one represents normal skin. The score is summed, range 5-50. Lower scores indicate closer resemblance to normal skin and are superior.</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="137"/>
                <count group_id="O2" value="138"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12" lower_limit="9" upper_limit="15"/>
                    <measurement group_id="O2" value="13" lower_limit="9" upper_limit="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were monitored from the time of randomization to 30 days postpartum.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Suture</title>
          <description>Subcuticular continuous suture (4-0 Monocryl Plus on PS2 needle or 4-0 Vicryl Plus on FS2 or PS2 needle)</description>
        </group>
        <group group_id="E2">
          <title>Staples</title>
          <description>Interrupted Ethicon Staples</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="370"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="376"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="370"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="376"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="370"/>
                <counts group_id="E2" subjects_affected="40" subjects_at_risk="376"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Wound Complications</sub_title>
                <description>Wound complications are a known risk of both cesarean closure methods.</description>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="370"/>
                <counts group_id="E2" events="40" subjects_affected="40" subjects_at_risk="376"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. A. Dhanya Mackeen</name_or_title>
      <organization>Geisinger</organization>
      <phone>570-714-1099</phone>
      <email>admackeen@geisinger.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

